The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression

Breast Cancer Research

Volumn 3, Issue 5, 2001, Pages 289-293

  Berx, G ^a   Van Roy, F ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

E cadherin; Methylation; Mutation; Transcriptional repression; Tumor suppression

Indexed keywords

CATENIN; CELL PROTEIN; UVOMORULIN;

ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; CHROMOSOME 16Q; CORRELATION FUNCTION; DOWN REGULATION; EPITHELIUM; GENE EXPRESSION; GENE INACTIVATION; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MODEL; PROGNOSIS; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CADHERINS; FEMALE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION;

EID: 0034852853     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr309     Document Type: Article

References (56)

1. Selective uncoupling of p120ctn from E-cadherin disrupts strong adhesion
2. Cadherins and catenins: Role in signal transduction and tumor progression
3. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
4. Role of morphogenetic factors in metastasis of mammary carcinoma cells
5. A causal role for E-cadherin in the transition from adenoma to carcinoma
6. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
7. KIP1
8. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin
9. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma
10. Anomalous expression of P-cadherin in breast carcinoma: Correlation with E-cadherin expression and pathological features
11. Expression and functional role of E- and P-cadherin in mouse mammary ductal morphogenesis and growth
12. Separating favorable from unfavorable prognostic markers in breast cancer: The role of E-cadherin
13. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas
14. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
15. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer
16. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma
17. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas
18. E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumorigenesis
19. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer
20. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
21. Reproducibility of a diagnosis of invasive lobular carcinoma
22. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
23. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients
24. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice
25. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma
26. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression
27. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer
28. E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers
29. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
30. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas
31. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling
32. DeltaN89beta-catenin induces precocious development differentiation, and neoplasia in mammary gland
33. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas
34. Epidemiology of breast carcinoma IV: Age and histologic tumor type
35. Relationship between breast histopathology and family history of breast cancer
36. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin
37. E-cadherin germline mutations in familial gastric cancer
38. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation
39. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
40. Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
41. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas
42. Mechanisms identified in the transcriptional control of epithelial gene expression
43. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
44. Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer
45. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
46. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements
47. Transcriptional defects underlie loss of E-cadherin expression in breast cancer
48. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
49. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
50. Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells
51. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells
52. Overexpression of erb-B2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene
53. Targeting expression of a transforming growth factor-beta-1 transgene to the pregnant mammary gland inhibits alveolar development and lactation
54. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors
55. TGF-b type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells
56. The two-handed E-box-binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion